Clinical research regulation in India-history, development, initiatives, challenges and controversies: Still long way to go

Journal of Pharmacy and Bioallied Sciences

Volumn 5, Issue 1, 2013, Pages 2-9

  Imran, Mohammed ^a   Najmi, Abul K ^b   Rashid, Mohammad F ^a   Tabrez, Shams ^a   Shah, Mushtaq A ^c  

^a HAMDARD UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

^c SGT Medical College   (India)

Author keywords

CDSCO; clinical research; drug and cosmetic act; drug and cosmetic rule; drug regulation

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; DRUG MARKETING; DRUG MONITORING; DRUG RESEARCH; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; FAMILY; GOVERNMENT; HEALTH; HUMAN; INDIA; LAW; MEDICAL ETHICS; MEDICAL SOCIETY; ORGANIZATION; PATENT; PHYSICIAN; PRIORITY JOURNAL; QUALITY CONTROL; REGISTRATION; REVIEW; WELFARE;

EID: 84875467956     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.106553     Document Type: Review

References (85)

1. Confederation of Indian Industry. Background paper. Conference on Clinical research: Roadmap for India, New Delhi: Sep 2003, 24-25. Available from: http://www.icriindia.com/pdf/conference-on-clinical-research-road-map-for- india.pdf. [Last accessed on 2012 Jul 07].
2. U.S. Government Printing Office. Code of Federal Regulation, Part 46. 102(d). Available from: http://ecfr.gpoaccess.gov/cgi/t/text/textidx?c=ecfr & sid=40b8414de2b96f123d892712afc06258&rgn=div5 & view=text and node=45:1.0.1.1.25 & idno=45#45:1.0.1.1.25.1.1.2. [Last accessed on 2012 Jul 07].
3. Maiti R, M R.Clinical trials in India. Pharmacol Res 2007;56:1-10.
4. RNCOS [Internet]. Booming Clinical Trials Market in India, Aug 2011, Available from: http://www.rncos.com/Report/IM564.htm. [Last accessed on 2012 Jul 07].
5. Modern Medicine (Home page). Lamberti MJ, Space S, Gammbrill S. Going global. Jun 1 2004. Available from: http://www.modernmedicine.com/ modernmedicine/article/articleDetail.jsp?id=98387. [Last accessed on 2012 Aug 17].
6. Applied Clinical Trials (Home page). Wechsler J. FDA seeks new approach to global challenges. 2011 Aug 01. Available from: http://www. appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp? id=734368. [Last accessed on 2012 Aug 17].
7. Jayasheel BG. Carrying out clinical trials in India. Available from: http://www.acunovalife.com/pdf/whitepapers/RAJ-Pharma%20June%202010- Jayasheel%20final.pdf. [Last accessed on 2012 Jul 04].
8. Federations of Indian chambers of commerce and industry; the Glorious metamorphosis: Compelling reasons for doing clinical research in India, Sep 2009. Available from: http://www.ficci.com/publication-page.asp?spid=20026. [Last accessed on 2012 Jul 07].
9. Social Sector: Volume II; Planning Commission, Government of India. Eleventh Five Year Plan (2007-2012). New Delhi: Oxford University Press; 2008.
10. Chatterjee P. Clinical trials in India: Ethical concerns. Bull World Health Organ 2008;86:581-2.
11. Varma S. India a hobted for clinical trials. Available from: http://www.timesofindia.indiatimes.com/articleshow/1776215.cms. [Last accessed on 2008 Mar 06].
12. Mehdiratta R, Parida DK, Saberwal G. Bio-business in brief: The challenges of clinical trials. Curr Sci 2007;93:1367-75.
13. Sinha K. India Overtakes china as a no.1 destination for clinical trials. Available from: http://www.timesofindia.indiatimes.com/India-overtakes-China- as-no1-destination-for-clinical-trials/articleshow/2927126.cms. [Last accessed on 2012 Jul 20].
14. Abraham A, Jones J, Vikram S. How to minimize low enrolling sites: A case study in diabetes. Perspect Clin Res 2010;1:25-8.
15. Pandiya A. Quality of Independent review board/ethics committee oversight in clinical trials in India. Perspect Clin Res 2011;2:45-7.
16. ICH harmonized tripartite guidelines. Guidelines for Good Clinical Practice E6. J Postgrad Med [serial online] 2001;47:45-50. Available from: http://www.jpgmonlins.com/text.asp?2001/47/1/45/235. [Last accessed on 2012 Jul 24].
17. Rai K. Integrated monitoring: Setting new standards for the next decade of clinical trial practice. Perspect Clin Res 2011;2:28-33.
18. Hunter P. The health of European medical research. Attempts are under way to update EU regulations, with the aim of harmonizing clinical research across the continent. EMBO Rep 2011;12:110-2.
19. Kapp MB. Ethical and Legal issue in research involving human subjects: Do you want a piece of me. J Clin Pathol 2006;59:335-9.
20. Bhatt A. Indian clinical trials: Paradigm shift from speed to quality? Perspect Clin Res 2012;3:1-3.
21. Pharmaceutical Policy-2002. Ministry of Chemicals and Fertilizers, Department of Chemicals and Petrochemicals. Available from: http://www. chemicals.nic.in/pharma4.htm. [Last accessed on 2012 Aug 17].
22. Singh H. Sir Ram Nath Chopra: A profile. J Young Pharm 2009;1:192-4.
23. The Drug and Cosmetic Act, 1940 and The Drugs and Cosmetic Rules, 1945 as amended time to time. Ministry of Health and Family Welfare, Government of India. Available from: http://www.cdsco.nic.in/Drugs&CosmeticAct.pdf. [Last accesseed on 2012 Jul 10].
24. Central Drugs Standards Control organization. Ministry of Health and Family Welfare. Available from: http://cdsco.nic.in/html/organisationalchart. htm. [Last accessed on 2012 Jul 04].
25. MedIndia (Home page). Drugs and cosmetics act, 1940-The drug consultative committee. Available from: http://www.medindia.net/indian-health-act/drugs-and- cosmetics-act-1940-the-drugs-consultative-committee.htm. [Last accessed on 2012 Aug 18].
26. Narrain S. A costly prescription. Frontline 2005;22:12-25.
27. Damodaran AD. Indian Patent Law in the post-TRIPS Decade: S and T Policy Appraisal. J Intellect Prop Rights 2008;13:414-23.
28. Tulasi GK, Rao BS. A detailed study of patent system for protection of inventions. Indian J Pharm Sci 2008;70:547-54.
29. Saha CN, Bhattacharya S. Intellectual property rights: An overview and implications in pharmaceutical industry. J Adv Pharm Technol Res 2011;2:88-93.
30. Otten A. The GATT TRIPS Agreement and health care in India. Natl Med J India 1995;8:1-3.
31. Thawani V, Gharpure K, Thawani M. Patent laws must be in the national interest. Indian J Pharmacol 2006;38:70-2.
32. Praveen Raj RS, "India moving to strong patent regime-challenges and Concerns, Scientist-IP management, Regional Research Laboratory, Trivandrum. Available from: http://www.Patentmatics.org/pub2005/pub10b.pdf on 13-10-2005. [Last accessed on 2012 Jul 07].
33. Health Group Criticizes India's New Drug Patent Law. Available from: http://www.Scitech-today.com/story.html? Story-id=31764 on 27-03-2005. [Last accessed on 2012 Jul 07].
34. Amended Schedule Y [Drug and Cosmetic act (2 nd amendment) rules]. 20 January 2005, New Delhi. Available from: http://www.cdsco.nic.in/html/ scheduleY%20(Amended%20Version2005)%20original.htm. [Last accessed on 2012 Jul 07].
35. ICMR, Ethical Guidelines for Biomedical Research on Human Participants, 2006. Available from: http://www.icmr.nic.in/ethical-guidelines.pdf. [Last accessed on 2012 Jul 07].
36. CDSCO, Good Clinical Practices for Clinical Research in India, Schedule Y (Amended Version-2005). Available from: http://cdsco.nic.in/html/GCP1.html. [Last accessed on 2012 Jul 07].
37. Nundy S, Gulhati CM. A new colonialism-Conducting clinical trials in India. N Engl J Med 2005;352:1633-6.
38. Thatte UM, Bavdeka SB. Clinical Research in India: Great expectations. J Postgrad Med 2008;54:318-23.
39. Viswanath K. Foreign firms drive surge in tech patents, trend reflects the more complex R and D work being done in India, MNCs outpace local peers. Live Mint, 2008 June 9.
40. Central Drug Standard Control Organization. Targeted Timelines for Approvals of Complete Applications by DCG(I) office. Available from: http://www.cdsco.nic.in/revised-new-timelines.pdf. [Last accessed on 2012 Jul 07].
41. Kumar M, Kher S. Regulatory consideration for conducting clinical trials in India. Regul Aff Focus 2007;12:26-31.
42. Kumar M. Practical aspects of conducting clinical trials in India. Regul Focus 2009;30-7. Available from: http://www.amarexcro.com/articles/docs/RAPS- Focus-Practical-Feb2009.pdf. [Last accessed on 2012 Sept 19].
43. Ghooi RB. Trials and tribulations of clinical research teaching and training. Perspect Clin Res 2010;1:139-42.
44. Patel KT, Chotai NP. Pharmaceutical GMP: Past, Present and Future-A review. Pharmazie 2008;63:251-5.
45. Sweatman J. Good clinical practice: A nuisance, a help or a necessity for clinical pharmacology? Br J Clin Pharmacol 2003;55:1-5.
46. Selvakumar R. Good laboratory practices. Indian J Clin Biochem 2010;25:221-4.
47. Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, Hitchcock R, et al. Guidelines on good clinical laboratory practices. J Pharm Biomed Anal 2008;46:18-29.
48. Guiding document for zonal and sub zonal. Available from: http://www.cdsco.nic.in/Guidance-doc-fuct-cdsco-subzonal/ guidingdocumentsforzona and subzonal&portoffices 17.06.2011.pdf. [Last accessed on 2012 Jul 07].
49. NPPA-Home page, National Pharmaceutical policy Authority. 2008. Available from: http://www.nppaindia.nic.in/index/.html. [Last accessed on 2012 Jul 07].
50. Drug Policy 2002. Available from: http://www.dbtbiosafety.nic.in/Files/ CD-IBSC/Fi-Les/2002.PDF. [Last accessed on 2012 Jul 07].
51. Drug (Price Control) Order 1995. Available from: http://www.nppaindia. nic.in/drugprice95/txt.html. [Last accessed on 2012 Jul 07].
52. Pharmaceutical policy. Feb 15, 2002. Available from: http://www. nppaindia.nic.in/May2002/policy02.html. [Last accessed on 2012 Jul 07].
53. Department of Biotechnology, Ministry of Science and Technology. Available from: http://www.dbtindia.nic.in/index.asp. [Last accessed on 2012 Jul 07].
54. Atomic Energy Regulatory Board. Available from: http://www.aerb.gov.in. [Last accessed on 2012 Jul 07].
55. Bhabha Atomic Research Centre. Government of India, department of Atomic energy. Available from: http://www.barc.ernet.in. [Last accessed on 2012 Jul 07].
56. Ministry of Health and Family Welfare. Available from: http://www.mohfw.nic.in. [Last accessed on 2012 Jul 07].
57. Department of Chemicals and Petrochemicals (home page), Ministry of Chemicals and Fertilizers. Available from: http://chemicals.nic.in. [Last accessed on 2012 Jul 07].
58. Ministry of Environment and Forest (home page). Available from: http://www.moef.nic.in/index.php. [Last accessed on 2012 Jul 07].
59. Ministry of Finance (Home page). Available from: http://www.finmin.nic. in. [Last accessed on 2012 Jul 07].
60. Department of Industrial Policy and Promotion, Ministry of Commerce and industry. Available from: http://dipp.nic.in/English/default.aspx. [Last accessed on 2012 Jul 07].
61. Department of science and technology, ministry of science and technology. Available from: http://www.dst.gov.in. [Last accessed on 2012 Jul 07].
62. Directorate general of foreign Trade, Ministry of Commerce and Industry. Available from: http://dgft.gov.in. [Last accessed on 2012 Jul 07].
63. The Poison Act, 1919. Available from: http://www.indiankanoon.org/doc/ 1399304. [Last accessed on 2012 Jul 07].
64. The Pharmacy Act, 1948. Available from: http://www.gujhealth.gov.in/ images/pdf/legis/pharmacy-act-1948.pdf. [Last accessed on 2012 Jul 07].
65. The Drugs and Magic (Objectionble Advertising) Act, 1954. Available from: http://www.rfhha.org/images/pdf/Hospital-Laws/Drugs-Magic-remedies- (%20advertisement)-act.pdf. [Last accessed on 2012 Jul 07].
66. The Narcotic Drugs and Psychotropic Substances Act, 1985. Available from: http://www.dor.gov.in/sites/upload-files/revenue/files/pdf/NDPS-Act-1985-as- amended.pdf. [Last accessed on 2012 Jul 07].
67. The Insecticides Act, 1968. Available from: http://www.cibric.nic.in/ Insecticides-act.htm. [Last accessed on 2012 Jul 07].
68. The Medicinal and Toilet preparation Act, 1985. Available from: http://www.dor.gov.in/medicinalandtoilet act. [Last accessed on 2012 Jul 07].
69. The Drug (Price Control) Order, 1995. Available from: http://www.nppaindia.nic.in/drugprice95/txt1.html. [Last accessed on 2012 Jul 07].
70. The Industries (Development and Regulation) Act, 1951. Available from: http://www.dipp.nic.in/English/policies/Industries-act1951.pdf. [Last accessed on 2012 Jul 07].
71. The Trade and Merchandise Act, 1958. Available from: http://www.indiaip. com/in-dia/trademarks/acts/tmact1958.htm. [Last accessed on 2012 Jul 07].
72. The Indian Patent Act, 1970. Available from: http://www.spicyip.com/docs/ statutecombined%20patents%20act%202005.pdf. [Last accessed on 2012 Jul 07].
73. The Design Act, 2000. Available from: http://www.ipindia.nic.in/ipr/ design/design-act.PDF. [Last accessed on 2012 Jul 07].
74. The Factories Act, 1948 (Amended on 1987). Available from: http://www.nihfw.nic.in/ndcnihfw/html/Legislations/The Factories Act 1948.htm. [Last accessed on 2012 Jul 07].
75. Srinivasan S. A stinging indictment of india's Drug regulatory Authority. Economic and Political weekly 2012;47:10-3.
76. Guidelines on approval of clinical trials and new drugs. Available from: http://www.cdsco.nic.in/Guidance-for-New-Drug-Approval.23.07.2011.pdf. [Last accessed on 2012 Jul 07].
77. World Medical Association. Declaration of Helsinki. Available from: http://www.wma.net/epolicy. [Last accessed on 2012 Jul 07].
78. CDSCO. Draft guidance for industry on reporting serious adverse events occurring in clinical trials. Available from: http://www.cdsco.nic.in/SAE%. 20GUIDELINES%2005-052011.pdf. [Last accessed on 2012 Jul 07].
79. Francis PA. Post marketing surveillance. Pharmabiz.com. 2012, May 30. Available from: http://www.pharmabiz.com/ArticleDetails.aspx?aid=69273&sid= 3. [Last accessed on 2012 Jul 07].
80. Tharyan P, Ghesri D. Registering clinical trials in India: A scientific and ethical imperative. Natl Med J India 2008;21:31-4.
81. Pharmacovigilance programme of India 2010. CDSCO, Ministry of Health and Family Welfare, Government of India. 2010. Nov. Available from: http://www.cdsco.nic.in/pharmacovigilance-intro.htm. [Last accessed on 2012 Jul 07].
82. Indian Pharmacopoeias Commission. NCC Pharmacovigilance programme of India. Available from: http://www.ipc.gov.in/index1.asp?linkid=222. [Last accessed on 2012 Jul 07].
83. Babu G. Centre releases draft rule for schedule Y-1 mandating registration of CROs. Pharmabiz.com, Mumbai, 2009, July 11. Available from: http://pharmabiz.com/NewsDetails.aspx?aid=51414 &sid=2. [Last accessed on 2012 Jul 07].
84. Alexander J. On-site inspection of clinical trials to be intensified by CDSCO teamdsoon. Pharmabiz.com, Mumbai, 2009, July 21. Available from: http://pharmabiz.com/NewsDetails.aspx?aid=51551 &sid=2. [Last accessed on 2012 Jul 07].
85. Dalvi B. Drug trials in children: Doubts and dilemmas. Ann Pediatr Cardiol 2008;1:81-2.